Product Information

IBUPROFEN 400 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0364 per EA under NDC 64380080906. Its NADAC has been published 429 times since Sep 5, 2018.

FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 400 MG TABLET

Ibuprofen
$0.0364per EA

Strength

400 mg/1

NDC

64380080906

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078329

FDA Approved

2/5/2009

TE Code

AB

On Market Since

8/24/2018

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 400 MG TABLET has been published 429 times since Sep 5, 2018, and over the history we have for it it has declined 6.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0364 per EA
All-time high$0.0577 (Sep 15, 2021)
All-time low$0.0336 (Sep 19, 2018)
52-week high$0.0420
52-week low$0.0364
Median price$0.0472
Average price$0.0465
Largest weekly change-25.2% (Nov 20, 2024)
Weeks tracked429
Tracking sinceSep 5, 2018

Price History

1W

-2.9%

1M

-6.7%

3M

-6.9%

6M

-11.1%

1Y

-12.1%

3Y

-24.0%

5Y

-29.3%

All

-6.0%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBUPROFEN 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 400 MG TABLET, manufactured by Strides Pharma Inc., is $0.0364 per EA (NDC 64380080906), effective Nov 18, 2026.

How has the price of IBUPROFEN 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 400 MG TABLET has declined 6.0%. It has been tracked across 429 weekly CMS publications since Sep 5, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 400 MG TABLET?

Since Sep 5, 2018, the NADAC for IBUPROFEN 400 MG TABLET has ranged from a low of $0.0336 (Sep 19, 2018) to a high of $0.0577 (Sep 15, 2021), with a median of $0.0472 per EA.

Are there cheaper alternatives to IBUPROFEN 400 MG TABLET?

14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IBUPROFEN 400 MG TABLET?

IBUPROFEN 400 MG TABLET (NDC 64380080906) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.